The effects of DNA methyltransferase inhibitors and histone deacetylase inhibitors on digit regeneration in mice

Regenerative Medicine

Volumn 5, Issue 2, 2010, Pages 201-220

  Wang, Gang ^a   Badylak, Stephen F ^b   Heber Katz, Ellen ^c   Braunhut, Susan J ^d   Gudas, Lorraine J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d University of Massachusetts Lowell   (United States)

Author keywords

Cell proliferation; Epigenetics; Msx1; Pharmacology; Regeneration; Regenerative medicine n retinoic acid n stem cells n transcription n wound healing

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CYCLINE; CYTOCHROME P450 26A1; DNA; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; MESSENGER RNA; PHOSPHATE BUFFERED SALINE; RETINAL DEHYDROGENASE; STEM CELL ANTIGEN 1; TRANSCRIPTION FACTOR MSX1; TRICHOSTATIN A; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 42;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CELL PROLIFERATION; CONTROLLED STUDY; DNA MODIFICATION; FEMALE; FINGER AMPUTATION; GENE EXPRESSION; HISTOCHEMISTRY; HISTOPATHOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; TISSUE REGENERATION;

AMPUTATION; ANIMALS; AZACITIDINE; FEMALE; FORELIMB; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACIDS; METHYLTRANSFERASES; MICE; MICE, INBRED C57BL; PROLIFERATING CELL NUCLEAR ANTIGEN; REGENERATION; RNA, MESSENGER; STAINING AND LABELING; TOES;

EID: 77949368108     PISSN: 17460751     EISSN: None     Source Type: Journal    
DOI: 10.2217/rme.09.91     Document Type: Article

References (87)

1. Han M, Yang X, Taylor G, Burdsal CA, Anderson RA, Muneoka K: Limb regeneration in higher vertebrates: developing a roadmap. Anat. Rec. B New Anat. 287(1), 14-24 (2005).
2. Kragl M, Knapp D, Nacu E et al.: Cells keep a memory of their tissue origin during axolotl limb regeneration. Nature 460(7251), 60-65 (2009).
3. Yokoyama H, Ogino H, Stoick-Cooper CL, Grainger RM, Moon RT: Wnt/b-catenin signaling has an essential role in the initiation of limb regeneration. Dev. Biol. 306(1), 170-178 (2007).
4. Stocum DL: Regenerative biology and engineering: strategies for tissue restoration. Wound Repair Regen. 6(4), 276-290 (1998).
5. Bryant SV, Endo T, Gardiner DM: Vertebrate limb regeneration and the origin of limb stem cells. Int. J. Dev. Biol. 46(7), 887-896 (2002).
6. Brockes JP, Kumar A: Appendage regeneration in adult vertebrates and implications for regenerative medicine. Science 310(5756), 1919-1923 (2005).
7. Borgens RB: Mice regrow the tips of their foretoes. Science 217(4561), 747-750 (1982).
8. Illingworth CM: Trapped fngers and amputated fnger tips in children. J. Pediatr. Surg. 9(6), 853-858 (1974).
9. Neufeld DA, Zhao W: Bone regrowth after digit tip amputation in mice is equivalent in adults and neonates. Wound Repair Regen. 3(4), 461-466 (1995).
10. Reginelli AD, Wang YQ, Sassoon D, Muneoka K: Digit tip regeneration correlates with regions of msx1 (hox 7) expression in fetal and newborn mice. Development 121(4), 1065-1076 (1995).
11. Han M, Yang X, Lee J, Allan CH, Muneoka K: Development and regeneration of the neonatal digit tip in mice. Dev. Biol. 315(1), 125-135 (2008).
12. Mohammad KS, Day FA, Neufeld DA: Bone growth is induced by nail transplantation in amputated proximal phalanges. Calcif. Tissue Int. 65(5), 408-410 (1999).
13. Allan CH, Fleckman P, Fernandes RJ et al.: Tissue response and msx1 expression after human fetal digit tip amputation in vitro. Wound Repair Regen. 14(4), 398-404 (2006).
14. Han M, Yang X, Farrington JE, Muneoka K: Digit regeneration is regulated by msx1 and BMP4 in fetal mice. Development 130(21), 5123-5132 (2003).
15. Masaki H, Ide H: Regeneration potency of mouse limbs. Dev. Growth Differ. 49(2), 89-98 (2007).
16. Chadwick RB, Bu L, Yu H et al.: Digit tip regrowth and differential gene expression in MRL/Mpj, DBA/2, and C57BL/6 mice. Wound Repair Regen. 15(2), 275-284 (2007).
17. Yakushiji N, Suzuki M, Satoh A et al.: Correlation between shh expression and DNA methylation status of the limb-specifc shh enhancer region during limb regeneration in amphibians. Dev. Biol. 312(1), 171-182 (2007).
18. Yakushiji N, Yokoyama H, Tamura K: Repatterning in amphibian limb regeneration: a model for study of genetic and epigenetic control of organ regeneration. Semin. Cell Dev. Biol. 20(5), 565-574 (2009).
19. Vigushin DM, Ali S, Pace PE et al.: Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin. Cancer Res. 7(4), 971-976 (2001).
20. Liu T, Kuljaca S, Tee A, Marshall GM: Histone deacetylase inhibitors: multifunctional anticancer agents. Cancer Treat. Rev. 32(3), 157-165 (2006).
21. Schroeder TM, Westendorf JJ: Histone deacetylase inhibitors promote osteoblast maturation. J. Bone Miner. Res. 20(12), 2254-2263 (2005).
22. De Boer J, Licht R, Bongers M, Van Der Klundert T, Arends R, Van Blitterswijk C: Inhibition of histone acetylation as a tool in bone tissue engineering. Tissue Eng. 12(10), 2927-2937 (2006).
23. Yildirim F, Gertz K, Kronenberg G et al.: Inhibition of histone deacetylation protects wildtype but not gelsolin-defcient mice from ischemic brain injury. Exp. Neurol. 210(2), 531-542 (2008).
24. Bar-Sela G, Jacobs KM, Gius D: Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cells. Cancer J. 13(1), 65-69 (2007).
25. Mongan NP, Gudas LJ: Valproic acid, in combination with all-trans retinoic acid and 5-aza-2́-deoxycytidine, restores expression of silenced RARb2 in breast cancer cells. Mol. Cancer Ther. 4(3), 477-486 (2005).
26. Marquez VE, Kelley JA, Agbaria R et al.: Zebularine: a unique molecule for an epigenetically based strategy in cancer chemotherapy. Ann. NY Acad. Sci. 1058, 246-254 (2005).
27. Gal-Yam EN, Saito Y, Egger G, Jones PA: Cancer epigenetics: modifcations, screening, and therapy. Annu. Rev. Med. 59, 267-280 (2008).
28. Ghoshal K, Bai S: DNA methyltransferases as targets for cancer therapy. Drugs Today (Barc) 43(6), 395-422 (2007).
29. Horswill MA, Narayan M, Warejcka DJ, Cirillo LA, Twining SS: Epigenetic silencing of maspin expression occurs early in the conversion of keratocytes to fbroblasts. Exp. Eye Res. 86(4), 586-600 (2008).
30. Gore SD, Baylin S, Sugar E et al.: Combined DNA methyltransferase and histone deacetylase inhibition in the treatment of myeloid neoplasms. Cancer Res. 66(12), 6361-6369 (2006).
31. Garcia-Manero G, Kantarjian HM, Sanchez-Gonzalez B et al.: Phase 1/2 study of the combination of 5-aza-2́-deoxycytidine with valproic acid in patients with leukemia. Blood 108(10), 3271-3279 (2006).
32. Hurtubise A, Momparler RL: Effect of histone deacetylase inhibitor LAQ824 on antineoplastic action of 5-aza-2́-deoxycytidine (decitabine) on human breast carcinoma cells. Cancer Chemother. Pharmacol. 58(5), 618-625 (2006).
33. Huangfu D, Maehr R, Guo W et al.: Induction of pluripotent stem cells by defned factors is greatly improved by small-molecule compounds. Nat. Biotechnol. 26(7), 795-797 (2008).
34. Montanaro F, Liadaki K, Volinski J, Flint A, Kunkel LM: Skeletal muscle engraftment potential of adult mouse skin side population cells. Proc. Natl Acad. Sci. USA 100(16), 9336-9341 (2003).
35. Asakura A: Stem cells in adult skeletal muscle. Trends Cardiovasc. Med. 13(3), 123-128 (2003).
36. Hosler BA, Larosa GJ, Grippo JF, Gudas LJ: Expression of rex-1, a gene containing zinc fnger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Mol. Cell Biol. 9(12), 5623-5629 (1989).
37. Mongan NP, Martin KM, Gudas LJ: The putative human stem cell marker, rex-1 (ZFP42): structural classifcation and expression in normal human epithelial and carcinoma cell cultures. Mol. Carcinog. 45(12), 887-900 (2006).
38. Mongan NP, Gudas LJ: Diverse actions of retinoid receptors in cancer prevention and treatment. Differentiation 75(9), 853-870 (2007).
39. Scotland KB, Chen S, Sylvester R, Gudas LJ: Analysis of rex1 (ZFP42) function in embryonic stem cell differentiation. Dev. Dyn. 238(8), 1863-1877 (2009).
40. Mccabe MT, Low JA, Daignault S, Imperiale MJ, Wojno KJ, Day ML: Inhibition of DNA methyltransferase activity prevents tumorigenesis in a mouse model of prostate cancer. Cancer Res. 66(1), 385-392 (2006).
41. Tang XH, Vivero M, Gudas LJ: Overexpression of CRABPI in suprabasal keratinocytes enhances the proliferation of epidermal basal keratinocytes in mouse skin topically treated with all-trans retinoic acid. Exp. Cell. Res. 314(1), 38-51 (2008).
42. Gillespie RF, Gudas LJ: Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARb(2), and Cyp26A1 in F9 embryonal carcinoma cells. J. Mol. Biol. 372(2), 298-316 (2007).
43. Holte H, Suo Z, Smeland EB, Kvaloy S, Langholm R, Stokke T: Prognostic value of lymphoma-specifc S-phase fraction compared with that of other cell proliferation markers. Acta Oncol. 38(4), 495-503 (1999).
44. Rogers MB, Hosler BA, Gudas LJ: Specifc expression of a retinoic acid-regulated, zinc-fnger gene, Rex-1, in preimplantation embryos, trophoblast and spermatocytes. Development 113(3), 815-824 (1991).
45. Hosler BA, Rogers MB, Kozak CA, Gudas LJ: An octamer motif contributes to the expression of the retinoic acid-regulated zinc fnger gene rex-1 (ZFP-42) in F9 teratocarcinoma cells. Mol. Cell. Biol. 13(5), 2919-2928 (1993).
46. Brivanlou AH, Gage FH, Jaenisch R, Jessell T, Melton D, Rossant J: Stem cells. Setting standards for human embryonic stem cells. Science 300(5621), 913-916 (2003).
47. Kashyap V, Rezende NC, Scotland KB et al.: Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the nanog, OCT4 and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell micro-RNAs. Stem Cells Devel. 18(7), 1093-1108 (2009).
48. Short B, Brouard N, Driessen R, Simmons PJ: Prospective isolation of stromal progenitor cells from mouse BM. Cytotherapy 3(5), 407-408 (2001).
49. Short B, Brouard N, Occhiodoro-Scott T, Ramakrishnan A, Simmons PJ: Mesenchymal stem cells. Arch. Med. Res. 34(6), 565-571 (2003).
50. Welm BE, Tepera SB, Venezia T, Graubert TA, Rosen JM, Goodell MA: Sca-1(POS) cells in the mouse mammary gland represent an enriched progenitor cell population. Dev. Biol. 245(1), 42-56 (2002).
51. Xin L, Lawson DA, Witte ON: The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc. Natl Acad. Sci. USA 102(19), 6942-6947 (2005).
52. Burger PE, Xiong X, Coetzee S et al.: Sca-1 expression identifes stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue. Proc. Natl Acad. Sci. USA 102(20), 7180-7185 (2005).
53. Toma JG, Akhavan M, Fernandes KJ et al.: Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3(9), 778-784 (2001).
54. Fernandes KJ, Mckenzie IA, Mill P et al.: A dermal niche for multipotent adult skin-derived precursor cells. Nat. Cell Biol. 6(11), 1082-1093 (2004).
55. Oh H, Bradfute SB, Gallardo TD et al.: Cardiac progenitor cells from adult myocardium: homing, differentiation, and fusion after infarction. Proc. Natl Acad. Sci. USA 100(21), 12313-12318 (2003).
56. Matsuura K, Nagai T, Nishigaki N et al.: Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J. Biol. Chem. 279(12), 11384-11391 (2004).
57. Petersen BE, Grossbard B, Hatch H, Pi L, Deng J, Scott EW: Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. Hepatology 37(3), 632-640 (2003).
58. Langton S, Gudas LJ: Cyp26A1 knockout embryonic stem cells exhibit reduced differentiation and growth arrest in response to retinoic acid. Dev. Biol. 315(2), 331-354 (2008).
59. Loudig O, Maclean GA, Dore NL, Luu L, Petkovich M: Transcriptional co-operativity between distant retinoic acid response elements in regulation of Cyp26A1 inducibility. Biochem. J. 392(Pt 1), 241-248 (2005).
60. Maden M, Hind M: Retinoic acid, a regeneration-inducing molecule. Dev. Dyn. 226(2), 237-244 (2003).
61. Niederreither K, Abu-Abed S, Schuhbaur B, Petkovich M, Chambon P, Dolle P: Genetic evidence that oxidative derivatives of retinoic acid are not involved in retinoid signaling during mouse development. Nat. Genet. 31(1), 84-88 (2002).
62. Yashiro K, Zhao X, Uehara M et al.: Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb. Dev. Cell 6(3), 411-422 (2004).
63. Zhao R, Daley GQ: From fbroblasts to IPS cells: induced pluripotency by defned factors. J. Cell. Biochem. 105(4), 949-955 (2008).
64. Sandell LL, Sanderson BW, Moiseyev G et al. RDH10 is essential for synthesis of embryonic retinoic acid and is required for limb, craniofacial, and organ development. Genes Dev. 21(9), 1113-1124 (2007).
65. Neufeld DA: Partial blastema formation after amputation in adult mice. J. Exp. Zool. 212(1), 31-36 (1980).
66. Revardel JL, Chebouki F: Etude de la reponse a l'amputation des phalanges chez la souris: role morphogenetique des epitheliums, stimulation de la chondrogenese. Can. J. Zool. 65, 3166-3176 (1987).
67. Yokoyama H: Initiation of limb regeneration: the critical steps for regenerative capacity. Dev. Growth Differ. 50(1), 13-22 (2008).
68. Gardiner DM, Endo T, Bryant SV: The molecular basis of amphibian limb regeneration: integrating the old with the new. Semin. Cell Dev. Biol. 13(5), 345-352 (2002).
69. Brockes JP, Kumar A: Plasticity and reprogramming of differentiated cells in amphibian regeneration. Nat. Rev. Mol. Cell. Biol. 3(8), 566-574 (2002).
70. Nakatani Y, Nishidate M, Fujita M, Kawakami A, Kudo A: Migration of mesenchymal cell fated to blastema is necessary for fsh fn regeneration. Dev. Growth Differ. 50(2), 71-83 (2008)
71. Broughton G 2nd, Janis JE, Attinger CE: The basic science of wound healing. Plast. Reconstr. Surg. 117(7 Suppl.), 12S-34S (2006).
72. Gurtner GC, Werner S, Barrandon Y, Longaker MT: Wound repair and regeneration. Nature 453(7193), 314-321 (2008).
73. Bruder SP, Fink DJ, Caplan AI: Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J. Cell. Biochem. 56(3), 283-294 (1994).
74. Jiang Y, Jahagirdar BN, Reinhardt RL et al.: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418(6893), 41-49 (2002).
75. Zuk PA, Zhu M, Mizuno H et al.: Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 7(2), 211-228 (2001).
76. Tamaki T, Akatsuka A, Ando K et al.: Identifcation of myogenic-endothelial progenitor cells in the interstitial spaces of skeletal muscle. J. Cell. Biol. 157(4), 571-577 (2002).
77. Stocum DL: Stem cells in regenerative biology and medicine. Wound Repair Regen. 9(6), 429-442 (2001).
78. Hsieh J, Nakashima K, Kuwabara T, Mejia E, Gage FH: Histone deacetylase inhibition-mediated neuronal differentiation of multipotent adult neural progenitor cells. Proc. Natl Acad. Sci. USA 101(47), 16659-16664 (2004).
79. Kramer OH, Gottlicher M, Heinzel T: Histone deacetylase as a therapeutic target. Trends Endocrinol. Metab. 12(7), 294-300 (2001).
80. Holmes C, Stanford WL: Concise review: stem cell antigen-1: expression, function, and enigma. Stem Cells 25(6), 1339-1347 (2007).
81. Kafadar KA, Yi L, Ahmad Y, So L, Rossi F, Pavlath GK: Sca-1 expression is required for effcient remodeling of the extracellular matrix during skeletal muscle regeneration. Dev. Biol. 326(1), 47-59 (2009).
82. Simon HG, Nelson C, Goff D, Laufer E, Morgan BA, Tabin C: Differential expression of myogenic regulatory genes and Msx-1 during dedifferentiation and redifferentiation of regenerating amphibian limbs. Dev. Dyn. 202(1), 1-12 (1995).
83. Odelberg SJ, Kollhoff A, Keating MT: Dedifferentiation of mammalian myotubes induced by Msx1. Cell 103(7), 1099-1109 (2000).
84. White JA, Beckett-Jones B, Guo YD et al.: cDNA cloning of human retinoic acid-metabolizing enzyme (HP450RAI) identifes a novel family of cytochromes p450. J. Biol. Chem. 272(30), 18538-18541 (1997).
85. Yokouchi Y, Ohsugi K, Sasaki H, Kuroiwa A: Chicken homeobox gene Msx-1: Structure, expression in limb buds and effect of retinoic acid. Development 113(2), 431-444 (1991).
86. Wang Y, Sassoon D: Ectoderm-mesenchyme and mesenchyme-mesenchyme interactions regulate Msx-1 expression and cellular differentiation in the murine limb bud. Dev. Biol. 168(2), 374-382 (1995).
87. Lateef H, Abatan OI, Aslam MN, Stevens MJ, Varani J: Topical pretreatment of diabetic rats with all-trans retinoic acid improves healing of subsequently induced abrasion wounds. Diabetes 54(3), 855-861 (2005).